Stephen Manale, MD
Surgery · Gonzales, LANPI 1861497026
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,000 of the $10,938 with a category attached, or 64.0%. Intuitive Surgical accounts for 84.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2020 at $9,084 and has fallen 98.7% since, to $120 in 2025.
Across 62 payments — averaging $176.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Davol Inc.$540
- Kerecis Limited$302
- W. L. Gore & Associates, Inc.$182
- Medtronic$165
- Boston Scientific$125
- plus $349 from 8 others
What the payments were for
- Travel & lodging$1,72016%
- Food & beverage$2,21820%
- Education$7,00064%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 30 | $9,274 |
| Davol Inc. | 7 | $540 |
| Kerecis Limited | 3 | $302 |
| W. L. Gore & Associates, Inc. | 3 | $182 |
| Medtronic | 3 | $165 |
| Boston Scientific | 2 | $125 |
| Johnson & Johnson | 3 | $103 |
| Zimmer Biomet | 1 | $92 |
| Smith+Nephew | 4 | $60 |
| KCI USA, Inc. | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 1 | $25 |
| Melinta Therapeutics, LLC | 1 | $13 |
| TELA Bio, Inc. | 1 | $12 |
| Pacira Pharmaceuticals Incorporated | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$8,549
- Kerecis Omega3 SurgiClose$602
- Kerecis Omega3 Marigen$529
- Kerecis Omega3 GraftGuide$283
- PHASIX$269
- Signia$120
- Watchman$111
How this compares
$10,938 in reported general payments places this provider in the 80th percentile of 381 surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 54 | $251 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $196 |
| Ciprofloxacin Hcl | 15 | $135 |
Paid to pharmacies, not to this prescriber.
Other surgery in Gonzales
- James WilliamsGonzales$11K
- John TaborBaton Rouge$567K
- Carlos GalvaniNew Orleans$352K
- Mark HausmannBaton Rouge$250K
- Joseph BuellNew Orleans$186K
- Daryl MarxBaton Rouge$157K
- Matias NautsLake Charles$112K
- Tracee ShortBaton Rouge$108K
- Kamel BraktaShreveport$95K
- Kerry ThibodeauxOpelousas$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.